ClinicalTrials.govpublic full text
Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma
multiple myeloma, akt inhibitor, hematologic malignancies, gsk2110183, bortezomib, dexamethasone, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 826202
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.